SCHEMBL564549

SCHEMBL564549

C=CCNc1cc(C(C)(C)c2ccccc2)ccc1O

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
KDM4E B2RXH2 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
GAA P10253 1/20 0.44
ESR1 P03372 4/20 0.44
ESR2 Q92731 3/20 0.44
CYP3A4 P08684 1/20 0.44
CNR1 P21554 4/20 0.42
CNR2 P34972 4/20 0.42
KLF10 Q13118 1/20 0.40
RORC P51449 1/20 0.37
CYP2D6 P10635 1/20 0.37
NR3C2 P08235 3/20 0.35
ALOX15 P16050 1/20 0.35
ALOX12 P18054 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL565866 0.93 ESR1 (0.46) ALDH1A1KDM4ESMN1; SMN2GAAESR1
SCHEMBL566122 0.90 ESR1 (0.46) ALDH1A1KDM4ESMN1; SMN2GAAESR1
SCHEMBL565964 0.89 ESR1 (0.43) ALDH1A1KDM4ESMN1; SMN2GAAESR1
SCHEMBL565833 0.89 CA12 (0.41) ALDH1A1KDM4ESMN1; SMN2GAAESR1
SCHEMBL564566 0.89 ALDH1A1 (0.45) ALDH1A1KDM4ESMN1; SMN2GAAESR1
SCHEMBL565071 0.88 ESR1 (0.39) ALDH1A1KDM4ESMN1; SMN2GAAESR1
SCHEMBL565501 0.81 ESR1 (0.42) ALDH1A1KDM4ESMN1; SMN2GAAESR1
SCHEMBL564785 0.79 ESR1 (0.46) ALDH1A1KDM4ESMN1; SMN2GAAESR1
SCHEMBL565593 0.78 ESR1 (0.43) ALDH1A1KDM4ESMN1; SMN2GAAESR1
SCHEMBL565583 0.78 ALDH1A1 (0.40) ALDH1A1KDM4ESMN1; SMN2GAAESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8674029-B2 Method of preparing stabilized polymeric systems using polymeric peroxides Sunocs LLC (US) 2014-03-18 US disclosed
US-20120035307-A1 PROCESS FOR MAKING STABLIZED POLYMERIC SYSTEMS WITH NANOSTRUCTURES SONG CHENGQIAN (US) 2012-02-09 US disclosed
US-20120035315-A1 METHOD OF PREPARING STABLIZED POLYMERIC SYSTEMS USING POLYMERIC PEROXIDES SONG CHENGQIAN (US) 2012-02-09 US disclosed
US-7498467-B2 Antioxidant and bisaminophenol derivative IDEMITSU KOSAN CO., LTD. (JP) 2009-03-03 US disclosed
US-20080161608-A1 ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE IDEMITSU KOSAN CO., LTD. (JP) 2008-07-03 US disclosed
US-20060208227-A1 Antioxidant and bisaminophenol derivative IDEMITSU LOSAN CO., LTD (JP) 2006-09-21 US disclosed
EP-1612254-A1 ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE IDEMITSU KOSAN COMPANY LIMITED (JP) 2006-01-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161608-A1 ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE CBR1, CBR3, HMOX1 ALDH1A1 204/4885KDM4E 3369/4885SMN1; SMN2 3254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.